SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (985)6/19/1999 2:48:00 PM
From: Mike McFarland  Read Replies (2) | Respond to of 1073
 
Ideally you would want to know why each person
does well, and when they outperform. After my
SoftQuad debacle last September (that was an
internet--XML play) I hunkered down in microcap
biotechs. My portfolio had bottomed out somewhere
around 31k by October 1st, and has rebounded to
as high as 60k a few weeks ago...though it gave
some of that back two weeks ago. I guess I figured
wrong and I'm up 20% YTD, but that is meaningless
in nanocap land, where both the market risk volatility
as well as individual stock risk is incredible.

So what is a person to do? (Maybe there are some biotech
newbies to this thread lurking)

Well sorry, I certainly do not have the answer, I wish
I could say buy and hold companies with great science is
the way to go--but we know management is half the equation.
I wish I could say buy Peter and Rick's top two picks--but
I don't really know these guys, we know they're brutally
honest on these threads, so that is good, but in general
you don't want to go around buying what others recommend
"do your own DD" is the cliche.

I think there is one thing we do know--that the biotech
mutual funds are probably not the way to go. FBIOX is
doing pretty well, but you shouldn't have to pay the
load, and this new fella is probably pretty green.

Finally, apologies for not posting the FBIOX holdings
and changes (the top ten are available on the Fidelity
website, but the changes in the amounts of smaller
holdings is what is interesting). I never received the
bi-annual update...maybe because I was in select money
market. With my select money in gold now, maybe I'll
get the select report soon, but no promises.



To: scaram(o)uche who wrote (985)6/20/1999 3:40:00 AM
From: Larry Liebman  Read Replies (2) | Respond to of 1073
 
Richard....I have continued to sit on my biotechs, being pleasantly surprised by SUGN(in my father-in-laws words, "You'll never go broke taking a profit"), now wondering whether to accept PNU into my life or diversify further. I am familiar with your praise for GLIA. Wonder if you have any thoughts regarding SUPG?